甲壳素脱乙酰酶产生菌产酶条件的优化

采用斜面培养和液体发酵培养产甲壳素脱乙酰酶的真菌构巢曲霉,并且研究了产酶条件。结果表明,构巢曲霉的最适产酶条件为：发酵培养基初始pH值为6.5、发酵时间为96h、培养温度为31℃、碳源浓度为2%、氮源浓度为2%、金属离子浓度为0.01mol/L、接种量为6%。     

一步法发酵菊芋产乙醇菌种的筛选及产酶条件、酶学性质的研究

从腐烂的菊芋及实验室保存的菌种中,选育到一株发酵菊芋产乙醇的菌株克鲁维酵母Kluyveromyces marxianus Y1。利用正交实验法对克鲁维酵母产菊粉酶的培养基组成及培养条件进行优化,确定培养基组成（g/L）为：菊粉40,酵母粉4,蛋白胨4,尿素1;初始pH5．0,温度30℃,150r／min条件下培养达到最佳产酶效果（57U／mL）。该菌株所产菊粉酶的性质测定结果表明：以菊粉为底物,该菊粉酶最适反应温度为55℃,在60℃以下稳定性很好,高于60℃时酶迅速失活;最适pH为5．0,pH4．6—5．2范围内酶稳定性很好;该酶属于外切型菊粉酶,体积分数为8％的乙醇对酶活力基本没有影响。     

枯草芽孢杆菌甲壳素脱乙酰酶的酶学性质

研究了甲壳素脱乙酰酶的热稳定性及酶的反应体系作用条件:酶(干重)添加量为40 mg.L-1,甲壳素底物(干重)质量浓度为75 mg.L-1,反应时间为90 m in,金属离子Mg2+对酶活有激活作用,在最适宜反应条件下的酶活为2250 U.L-1。甲壳素脱乙酰酶的酶解方式为外切酶型,酶降解终产物对酶活力有抑制作用,酶对甲壳素有一定的降解作用。     

一株产乙酰酯酶细菌筛选、鉴定及酶学性质研究

【目的】利用筛选培养基,从肉牛瘤胃液中分离筛选产乙酰酯酶的细菌菌株,并研究菌株的产酶特征。【方法】利用厌氧培养技术,以木质素为唯一碳源,筛选并驯化所得菌株。根据菌株16S rDNA序列分析、革兰氏染色、伊红美蓝培养基培养、甲基红试验和柠檬酸盐利用试验,鉴定菌株。采用对-硝基苯乙酯测定酶活力。【结果】筛选得到产乙酰酯酶活力较高细菌菌株RB1,初步鉴定为Escherichia coli。菌株RB1的生长曲线表明,0 42 h为菌株的延迟期,42 60 h为菌株的对数期,60 66 h为菌株的稳定期,66 86 h为菌株的衰亡期。菌株所产乙酰酯酶最适温度为40°C,最适pH为8.0,在最适温度与pH条件下,培养基中添加玉米秸秆粉,乙酰酯酶最高酶活力达到0.52 U/mL。【结论】筛选获得产乙酰酯酶的细菌菌株RB1,其乙酰酯酶活力高于已报道的菌株,是一株具有研究和应用潜力的产乙酰酯酶的菌株。     

氧化铁鞘细菌铁氧化酶最适产酶条件及其酶学特性的研究

对氧化铁鞘细菌FC990 1菌株的铁氧化酶最适产酶条件及酶学特性进行了研究。菌株最适产酶培养基为 (g/L) :柠檬酸铁胺 10g ,NaNO3 1.2g,MgSO4·7H2 O 0 .5g ,K2 HPO4·7H2 O 0 .5g ,CaCl2 0 .0 15g ,ZnSO4·7H2 O 0 .0 0 0 5g。最适产酶条件为 :温度 30℃ ,起始pH7.0 ,接种量 2 % ,15 0mL三角瓶装 5 0mL ,15 0r/min振荡培养 72h。铁氧化酶最适pH为7.5 ,最适温度为 30℃。金属离子Ca2 、Mg2 、Zn2 对酶有激活和稳定作用 ;Cu2 、Hg2 、Al3 则抑制酶的活性 ;Fe2 、K 、Na 对酶活性影响不明显。     

钝齿棒杆菌中异源表达N-乙酰鸟氨酸脱乙酰基酶合成L-鸟氨酸的研究

目的:对一株产鸟氨酸的钝齿棒杆菌Corynebacterium crenatum SYPA5-5/△proB/△argF(SYPO-1)进行代谢工程改造,筛选不同细菌来源的N-乙酰鸟氨酸脱乙酰基酶在大肠杆菌中克隆与表达,纯化后对其进行酶学性质的比较;将黏质沙雷氏菌Serratia marcescens Y213来源的Smarg E基因编码的N-乙酰鸟氨酸脱乙酰基酶在L-鸟氨酸生产菌株C.crenatum SYPO-1中过量表达,进一步提高L-鸟氨酸的产量。方法:通过利用pDXW10穿梭质粒对不同来源的N-乙酰鸟氨酸脱乙酰化酶进行克隆表达和酶学性质比较,选择性质最优来源的N-乙酰鸟氨酸脱乙酰基酶编码基因Smarg E在产L-鸟氨酸重组钝齿棒杆菌中表达,考察重组菌株发酵过程中参数的变化。结果:来源于S.marcescens Y213的N-乙酰鸟氨酸脱乙酰基酶比酶活最高为798.98U/mg,最适pH为7,最适温度为37℃,0.1mmol/L的Mg~(2+)、Li~+、Mn~(2+)促进酶的比酶活提高了50%;在钝齿棒杆菌中表达N-乙酰鸟氨酸脱乙酰基酶酶活达到128.4U/ml,显著提高了钝齿棒杆菌中胞内乙酰基循环水平;5L发酵罐发酵重组菌株96h,L-鸟氨酸的产量达到38.5g/L,比出发菌株,L-鸟氨酸的产量提高了33.2%,产率达0.401g/(L·h)。结论:筛选出最佳来源的N-乙酰鸟氨酸脱乙酰基酶,在鸟氨酸生产菌株C.crenatum(SYPO-1)中过量表达,可以促进鸟氨酸的前体物质N-乙酰鸟氨酸的快速消耗,实现鸟氨酸的积累。     

脱乙酰壳聚糖固定化宇佐美曲霉木聚糖酶及固定化酶的性质和应用(英文)

研究壳聚糖吸附和戊二醛交联对木聚糖酶固定化条件 .将酶液加入到经醋酸溶液处理过的脱乙酰壳聚糖的pH 4 8的悬液中 ,加入浓度为 0 3%～ 0 4 %的戊二醛溶液 ,室温下 ,8h后得到固定化酶 .固定化酶的半失活温度比游离酶高 ,由 5 1℃升至 71℃ ,Km 值由游离酶的 1 2mg ml增加到1 5mg ml ,最适反应温度也由 5 5℃增加到 71℃ ,而最适反应pH由 4 6下降到 3 8.该固定化木聚糖酶可用于制造低聚木糖 .经过 10次连续应用实验后 ,该固定化酶的活力保持 81%     

木霉菌株T6木聚糖酶固态发酵条件和酶学性质研究

研究了碳源和氮源、起始pH、接种量及温度等条件对一野生型木霉Trichodermasp.T6菌株固态发酵产木聚糖酶的影响。在28℃培养4d后,酶活力可达1918IU／g干培养物。酶的最适反应温度为50℃,最适反应pH4．5。不同温度保温1h后,测定酶的半失活温度为47．7℃,酶的pH稳定性也进行了研究。     

球孢白僵菌Bb174固态发酵产几丁质酶产酶及酶学特征研究

对球孢白僵菌(Beauveria bassiana)Bb174产几丁质酶进行了固态发酵条件及酶学特征的研究．结果表明,以4：1麸皮：蚕蛹粉、蛋白胨1g·L^-1作为产酶最适培养基,在7．5g培养基中接种3ml液态种子,自然pH下28℃培养2d,酶活可达最高,为126U·g^-1(干培养基)．粗酶液的最适反应温度为40℃,最适反应pH5．0,在30-70℃保温1h,得半失活温度48℃．在30--40℃、pH4～6范围内,酶的性质最稳定．根据Lineweaver-Burk作图法,得到该酶的动力学参数Km为0．52mg·ml^-1,Vm为0．7△E680·h^-1．     

湘江河岸土壤中高产甲壳素脱乙酰酶菌株的筛选及鉴定

【目的】甲壳素脱乙酰酶(CDA)是将天然甲壳素生物转化为可商品化利用的壳聚糖的关键酶。本文旨在从湘江河岸的土壤中筛选可高产CDA的新菌株。【方法】以甲壳素为唯一碳源,利用4'-硝基乙酰苯胺为显色剂,通过变色圈法进行产CDA菌株初筛,产酶活性分析复筛;通过形态学和ITS区序列特征对菌株进行鉴定。【结果】从湘江(长沙段)河岸边的土壤中分离出的117株菌株中筛选到可产CDA的菌株30株,其中4株具有较强产CDA的能力。进一步经发酵产酶分析验证,菌株A1具有较强的产CDA能力,其胞外CDA酶活高达13.21 U/m L。结合形态学和ITS区序列特征,菌株A1初步鉴定为层生镰孢菌。【结论】从湘江河岸边的土壤中筛选到可高产CDA的菌株A1,具有较好的开发应用前景。     

Recent advances in the study of Kaposi's sarcoma-associated herpesvirus replication and pathogenesis

It has now been over twenty years since a novel herpesviral genome was identified in Kaposi's sarcoma biopsies. Since then, the cumulative research effort by molecular biologists, virologists, clinicians, and epidemiologists alike has led to the extensive characterization of this tumor virus, Kaposi's sarcoma-associated herpesvirus(KSHV; also known as human herpesvirus 8(HHV-8)), and its associated diseases. Here we review the current knowledge of KSHV biology and pathogenesis, with a particular emphasis on new and exciting advances in the field of epigenetics. We also discuss the development and practicality of various cell culture and animal model systems to study KSHV replication and pathogenesis.     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid

Microbial resistance to antibiotics is an unresolved global concern, which needs urgent and coordinated action. One of the guidelines of the Centers for Disease Control and Preventions (CDC) to combat antibiotic resistance is the development of new antibiotics to treat drug-resistant bacteria. In our effort to find new antibiotics, we report the synthesis and antimicrobial studies of 30 new pyrazole derivatives. These novel molecules have been synthesized by using readily available starting materials and benign reaction conditions. Some of these molecules have shown activity with MIC values as low as 0.78?µg/mL against four bacterial strains; Staphylococcus aureus, methicillin-resistant S. aureus, Bacillus subtilis, and Acinetobacter baumannii. Furthermore, active molecules are non-toxic to mammalian cell line.

     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

Cyclin-dependent kinases (CDKs) and Polo-like kinases (PLKs) play key role in the regulation of the cell cycle. The aim of our study was originally the further development of our recently discovered polo-like kinase 1 (PLK1) inhibitors. A series of new 2,4-disubstituted pyrimidine derivatives were synthesized around the original hit, but their PLK1 inhibitory activity was very poor. However the novel compounds showed nanomolar CDK9 inhibitory activity and very good antiproliferative effect on multiple myeloma cell lines (RPMI-8226).